Landmark Court Ruling In UK Could Pave Way For Cheaper, Generic PrEP

Photo courtesy of BigStock/Mbruxelle
Photo courtesy of BigStock/Mbruxelle

Photo courtesy of BigStock/Mbruxelle

GayStarNews reports that Britain’s High Court today ruled to overturn pharmaceutical company Gilead Science’s patent extension on Truvada, the HIV medication also used for PrEP (Pre-Exposure Prophylaxis) which, when taken as advised, stops HIV negative people acquiring HIV.

Read the full story at GayStarNews

Lavender Magazine

5100 Eden Ave, Suite 107
Edina, MN 55436
612.436.4660

Lav Link Newsletter

©2022 Lavender Media, Inc.